Company performance
Current Price
as of Jan 07, 2025$19.67
P/E Ratio
N/A
Market Cap
$2.45B
- APAM
Description
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Metrics
Overview
- HQPasadena, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerARWR
- Price$19.67+0.87%
Trading Information
- Market cap$2.45B
- Float93.24%
- Average Daily Volume (1m)1,369,208
- Average Daily Volume (3m)1,454,240
- EPS-$5.00
Company
- Revenue$3.55M
- Rev growth (1yr)-98.52%
- Net income-$599.49M
- Gross margin-423.66%
- EBITDA margin-16,403.41%
- EBITDA-$582.49M
- EV$2.50B
- EV/Revenue703.12
- P/EN/A
- P/S663.52
- P/B13.19
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset